Leonardo Salas-Zapata1, Lina Sofía Palacio-Mejía2, Belkis Aracena-Genao3, Juan Eugenio Hernández-Ávila4, Emmanuel Salvador Nieto-López1. 1. Facultad Nacional de Salud Pública "Héctor Abad Gómez", Universidad de Antioquia, Medellín, Colombia. 2. Centro de Información para Decisiones de Salud Pública, CONACYT-Instituto Nacional de Salud Pública, Cuernavaca, México. Electronic address: lpalacio@insp.mx. 3. Centro de Investigación en Evaluación y Encuestas, Instituto Nacional de Salud Pública, Cuernavaca, México. 4. Centro de Información para Decisiones de Salud Pública, Instituto Nacional de Salud Pública, Cuernavaca, México.
Abstract
OBJECTIVE: To estimate the direct costs related to hospitalizations for diabetes mellitus and its complications in the Mexican Institute of Social Security METHODS: The hospital care costs of patients with diabetes mellitus using diagnosis-related groups in the IMSS (Mexican Institute of Social Security) and the hospital discharges from the corresponding E10-E14 codes for diabetes mellitus were estimated between 2008-2013. Costs were grouped according to demographic characteristics and main condition, and were estimated in US dollars in 2013. RESULTS: 411,302 diabetes mellitus discharges were recorded, representing a cost of $1,563 million. 52.44% of hospital discharges were men and 77.26% were for type 2 diabetes mellitus. The biggest cost was attributed to peripheral circulatory complications (34.84%) and people from 45-64 years of age (47.1%). Discharges decreased by 3.84% and total costs by 1.75% in the period analysed. The complications that caused the biggest cost variations were ketoacidosis (50.7%), ophthalmic (22.6%) and circulatory (18.81%). CONCLUSIONS: Hospital care for diabetes mellitus represents an important financial challenge for the IMSS. The increase in the frequency of hospitalisations in the productive age group, which affects society as a whole, is an even bigger challenge, and suggests the need to strengthen monitoring of diabetics in order to prevent complications that require hospital care.
OBJECTIVE: To estimate the direct costs related to hospitalizations for diabetes mellitus and its complications in the Mexican Institute of Social Security METHODS: The hospital care costs of patients with diabetes mellitus using diagnosis-related groups in the IMSS (Mexican Institute of Social Security) and the hospital discharges from the corresponding E10-E14 codes for diabetes mellitus were estimated between 2008-2013. Costs were grouped according to demographic characteristics and main condition, and were estimated in US dollars in 2013. RESULTS: 411,302 diabetes mellitus discharges were recorded, representing a cost of $1,563 million. 52.44% of hospital discharges were men and 77.26% were for type 2 diabetes mellitus. The biggest cost was attributed to peripheral circulatory complications (34.84%) and people from 45-64 years of age (47.1%). Discharges decreased by 3.84% and total costs by 1.75% in the period analysed. The complications that caused the biggest cost variations were ketoacidosis (50.7%), ophthalmic (22.6%) and circulatory (18.81%). CONCLUSIONS: Hospital care for diabetes mellitus represents an important financial challenge for the IMSS. The increase in the frequency of hospitalisations in the productive age group, which affects society as a whole, is an even bigger challenge, and suggests the need to strengthen monitoring of diabetics in order to prevent complications that require hospital care.
Keywords:
Complicaciones de la diabetes; Costos directos de servicios; Diabetes complications; Diagnosis-related groups; Direct service costs; Grupos relacionados por el diagnóstico; Hospitalisation; Hospitalización; Mexico; México; Seguridad social; Social security
Authors: Gabriel Lazcano-Gomez; Jeffrey R Soohoo; Anne Lynch; Levi N Bonell; Karina Martinez; Mauricio Turati; Roberto Gonzalez-Salinas; Jesus Jimenez-Roman; Malik Y Kahook Journal: J Curr Glaucoma Pract Date: 2017-08-05